[HTML][HTML] Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation
T Lanitis, T Kongnakorn, L Jacobson, A De Geer - Thrombosis research, 2014 - Elsevier
Introduction Atrial fibrillation (AF), one of the major risk factors for stroke, imposing a
substantial burden to the Swedish health care system. Apixaban has demonstrated …
substantial burden to the Swedish health care system. Apixaban has demonstrated …
[HTML][HTML] Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
T Lanitis, T Kongnakorn, L Jacobson… - Thrombosis …, 2014 - thrombosisresearch.com
Introduction Atrial fibrillation (AF), one of the major risk factors for stroke, imposing a
substantial burden to the Swedish health care system. Apixaban has demonstrated …
substantial burden to the Swedish health care system. Apixaban has demonstrated …
[PDF][PDF] Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
T Lanitis, T Kongnakorn, L Jacobson, A De Geer - Thrombosis Research, 2014 - core.ac.uk
Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention
in Patients with Atrial Fibrillation Page 1 Regular Article Cost-effectiveness of Apixaban versus …
in Patients with Atrial Fibrillation Page 1 Regular Article Cost-effectiveness of Apixaban versus …
Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
T Lanitis, T Kongnakorn, L Jacobson, A De Geer - Thrombosis Research, 2014 - infona.pl
Atrial fibrillation (AF), one of the major risk factors for stroke, imposing a substantial burden
to the Swedish health care system. Apixaban has demonstrated superiority to warfarin and …
to the Swedish health care system. Apixaban has demonstrated superiority to warfarin and …
Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation.
T Lanitis, T Kongnakorn, L Jacobson… - Thrombosis …, 2014 - europepmc.org
Materials and methods A Markov cohort model was constructed to characterise the
consequences of anticoagulant treatment with regards to thromboembolic and bleeding …
consequences of anticoagulant treatment with regards to thromboembolic and bleeding …
Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation
T Lanitis, T Kongnakorn, L Jacobson… - Thrombosis …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction Atrial fibrillation (AF), one of the major risk factors for stroke, imposing a
substantial burden to the Swedish health care system. Apixaban has demonstrated …
substantial burden to the Swedish health care system. Apixaban has demonstrated …
[PDF][PDF] Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
T Lanitis, T Kongnakorn, L Jacobson… - Thrombosis …, 2014 - scholar.archive.org
Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention
in Patients with Atrial Fibrillation Page 1 Regular Article Cost-effectiveness of Apixaban versus …
in Patients with Atrial Fibrillation Page 1 Regular Article Cost-effectiveness of Apixaban versus …
[PDF][PDF] Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
T Lanitis, T Kongnakorn, L Jacobson, A De Geer - 2014 - researchgate.net
Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention
in Patients with Atrial Fibrillation Page 1 Regular Article Cost-effectiveness of Apixaban versus …
in Patients with Atrial Fibrillation Page 1 Regular Article Cost-effectiveness of Apixaban versus …